Showing results (81-90 of 206) with videos related to

Sort By:
Pageof 21
Drug Design, Development and Therapy|February 1, 2017
Comparison of the long-term efficacy and safety of generic Tacrobell with original tacrolimus (Prograf) in kidney transplant recipientsSeung Yeon Son, Hye Ryoun Jang, Jung Eun Lee, et al.
Korean Journal of Hepato-Biliary-Pancreatic Surgery|July 9, 2015
Primary hepatic neuroendocrine carcinomaJong Man Kim, Se Yeong Kim, Choon Hyuck David Kwon, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 7, 2025
Risk Prediction and Management of BKPyV-DNAemia in Kidney Transplant Recipients: A Multicenter Analysis of Immunosuppressive StrategiesJin-Myung Kim, Hye Eun Kwon, Ahram Han, et al.
Hepato-Gastroenterology|April 10, 2013
PIVKA-II is a useful marker in patients with modified UICC T3 stage hepatocellular carcinomaJong Man Kim, Choon Hyuck David Kwon, Jae-Won Joh, et al.
World Journal of Surgical Oncology|February 26, 2013
The effect of alkaline phosphatase and intrahepatic metastases in large hepatocellular carcinomaJong Man Kim, Choon Hyuck David Kwon, Jae-Won Joh, et al.
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|January 17, 2017
Differences in Peripheral Blood Lymphocytes between Brand-Name and Generic Tacrolimus Used in Stable Liver Transplant RecipientsJong Man Kim, Choon Hyuck David Kwon, Jae-Won Joh, et al.
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|October 14, 2016
Changes in T Cells After ABO-Incompatible Liver TransplantationJong Man Kim, Choon Hyuck David Kwon, Jae-Won Joh, et al.
Hepato-Gastroenterology|April 29, 2015
Intrahepatic metastasis is more risky than multiple occurrence in hepatocellular carcinoma patients after curative liver resectionJong Man Kim, Choon Hyuck David Kwon, Jae-Won Joh, et al.
Pageof 21